These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1122 related articles for article (PubMed ID: 33248962)

  • 21. Superiority of left heart deformation in early anthracycline-related cardiac dysfunction detection.
    Giang M N; Nguyen H H; Vo DT; Ho Huynh Quang T; Phan DTH; Chau NH
    Open Heart; 2023 Nov; 10(2):. PubMed ID: 38011990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics-Related Cardiac Dysfunction.
    Narayan HK; French B; Khan AM; Plappert T; Hyman D; Bajulaiye A; Domchek S; DeMichele A; Clark A; Matro J; Bradbury A; Fox K; Carver JR; Ky B
    JACC Cardiovasc Imaging; 2016 Oct; 9(10):1131-1141. PubMed ID: 27085442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular magnetic resonance characterization of myocardial tissue injury in a miniature swine model of cancer therapy-related cardiovascular toxicity.
    Nakata K; Kucukseymen S; Cai X; Yankama T; Rodriguez J; Sai E; Pierce P; Ngo L; Nakamori S; Tung N; Manning WJ; Nezafat R
    J Cardiovasc Magn Reson; 2024 Summer; 26(1):101033. PubMed ID: 38460840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Early Left Atrial Functional Decline in Predicting Cardiotoxicity in HER2 Positive Breast Cancer Patients Treated With Trastuzumab.
    Bergamini C; Niro L; Springhetti P; Ferri L; Trento L; Minnucci I; Maffeis C; Tafciu E; Rossi A; Fiorio E; Benfari G; Ribichini F
    Cardiovasc Toxicol; 2024 Jun; 24(6):550-562. PubMed ID: 38696070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline LV ejection fraction by cardiac magnetic resonance and 2D echocardiography after ST-elevation myocardial infarction - influence of infarct location and prognostic impact.
    Schwaiger JP; Reinstadler SJ; Tiller C; Holzknecht M; Reindl M; Mayr A; Graziadei I; Müller S; Metzler B; Klug G
    Eur Radiol; 2020 Jan; 30(1):663-671. PubMed ID: 31428825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes: The SUCCOUR Trial.
    Negishi T; Thavendiranathan P; Negishi K; Marwick TH;
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1098-1105. PubMed ID: 29909105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Speckle tracking echocardiography predicts early subclinical anthracycline cardiotoxicity in patients with breast cancer.
    Tang Q; Jiang Y; Xu Y; Xia H
    J Clin Ultrasound; 2017 May; 45(4):222-230. PubMed ID: 27910996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2D and 3D strain for detection of subclinical anthracycline cardiotoxicity in breast cancer patients: a balance with feasibility.
    Santoro C; Arpino G; Esposito R; Lembo M; Paciolla I; Cardalesi C; de Simone G; Trimarco B; De Placido S; Galderisi M
    Eur Heart J Cardiovasc Imaging; 2017 May; 18(8):930-936. PubMed ID: 28379383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer.
    Arciniegas Calle MC; Sandhu NP; Xia H; Cha SS; Pellikka PA; Ye Z; Herrmann J; Villarraga HR
    BMC Cancer; 2018 Oct; 18(1):1037. PubMed ID: 30359235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular mechanics assessed by two-dimensional echocardiography and cardiac magnetic resonance imaging: comparison of high-resolution speckle tracking and feature tracking.
    Aurich M; Keller M; Greiner S; Steen H; Aus dem Siepen F; Riffel J; Katus HA; Buss SJ; Mereles D
    Eur Heart J Cardiovasc Imaging; 2016 Dec; 17(12):1370-1378. PubMed ID: 27013249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automated assessments of circumferential strain from cine CMR correlate with LVEF declines in cancer patients early after receipt of cardio-toxic chemotherapy.
    Jolly MP; Jordan JH; Meléndez GC; McNeal GR; D'Agostino RB; Hundley WG
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):59. PubMed ID: 28768517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Echocardiography and cardiovascular magnetic resonance based evaluation of myocardial strain and relationship with late gadolinium enhancement.
    Erley J; Genovese D; Tapaskar N; Alvi N; Rashedi N; Besser SA; Kawaji K; Goyal N; Kelle S; Lang RM; Mor-Avi V; Patel AR
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):46. PubMed ID: 31391036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year left ventricular systolic function of percutaneous coronary intervention vs optimal medical therapy for patients with single coronary chronic total occlusion.
    Meng S; Qiu L; Wu J; Huang R; Wang H
    Echocardiography; 2021 Feb; 38(2):368-373. PubMed ID: 33475185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Myocardial Strain Imaging in Cancer Therapy-Related Cardiac Dysfunction.
    Chaganti BT; Negishi K; Okajima K
    Curr Cardiol Rep; 2022 Jun; 24(6):739-748. PubMed ID: 35522421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Test-retest reliability of left and right ventricular systolic function by new and conventional echocardiographic and cardiac magnetic resonance parameters.
    Houard L; Militaru S; Tanaka K; Pasquet A; Vancraeynest D; Vanoverschelde JL; Pouleur AC; Gerber BL
    Eur Heart J Cardiovasc Imaging; 2021 Sep; 22(10):1157-1167. PubMed ID: 32793957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between regional left ventricular dysfunction and cancer-therapy-related cardiac dysfunction.
    Saijo Y; Kusunose K; Okushi Y; Yamada H; Toba H; Sata M
    Heart; 2020 Nov; 106(22):1752-1758. PubMed ID: 32209616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines.
    Thavendiranathan P; Houbois C; Marwick TH; Kei T; Saha S; Runeckles K; Huang F; Shalmon T; Thorpe KE; Pezo RC; Prica A; Maze D; Abdel-Qadir H; Connelly KA; Chan J; Billia F; Power C; Hanneman K; Wintersperger BJ; Brezden-Masley C; Amir E
    Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):515-525. PubMed ID: 37120736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
    Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M
    Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Features of trastuzumab-related cardiac dysfunction: deformation analysis outside left ventricular global longitudinal strain.
    Nhat GM; Hai NH; Duc VT; Tri HHQ; Hoa CN
    Front Cardiovasc Med; 2024; 11():1291180. PubMed ID: 38312233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal changes of right ventricular deformation mechanics during trastuzumab therapy in breast cancer patients.
    Keramida K; Farmakis D; Bingcang J; Sulemane S; Sutherland S; Bingcang RA; Ramachandran K; Tzavara C; Charalampopoulos G; Filippiadis D; Kouris N; Nihoyannopoulos P
    Eur J Heart Fail; 2019 Apr; 21(4):529-535. PubMed ID: 30811091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.